menu
    • menu

    Company profile for Acurx Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Acurx Pharmaceuticals is a privately held clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acurx PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    22 Camelot Court
 White Plains, NY 10603
    Telephone
    Telephone
    914-949-3898
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.acurxpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Health~Holland Grants Research Funding for DNA Pol IIIC Drugs
    Health~Holland Grants Research Funding for DNA Pol IIIC Drugs

    18 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/healthholland-awards-another-innovative-research-grant-for-dna-pol-iiic-inhibitors-to-leiden-university-medical-center-and-acurx-pharmaceuticals-302617303.html

    PR NEWSWIRE
    18 Nov 2025
    Share Share
    Acurx Pharma Reports Q3 Results & Business Updates
    Acurx Pharma Reports Q3 Results & Business Updates

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-inc-reports-third-quarter-results-and-provides-business-update-302608077.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    Acurx Publishes Unique DNA Pol IIIC Targeting In Nature
    Acurx Publishes Unique DNA Pol IIIC Targeting In Nature

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acurx-announces-publication-in-the-nature-communications-scientific-journal-documenting-its-unique-targeting-of-dna-pol-iiic-gram-positive-priority-pathogens-302608275.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    Acurx Data Shows Gut-Selective Effect of DNA pol IIIC Antibiotics
    Acurx Data Shows Gut-Selective Effect of DNA pol IIIC Antibiotics

    28 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acurx-announces-new-data-on-its-dna-pol-iiic-inhibitor-antibiotics-demonstrating-a-potential-class-effect-of-gut-microbiome-selectivity-presented-at-idweek-2025-scientific-conference-302593922.html

    PR NEWSWIRE
    28 Oct 2025
    Share Share
    Acurx Pharma To Present Q3 2025 Financials And Business Update
    Acurx Pharma To Present Q3 2025 Financials And Business Update

    27 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-to-discuss-third-quarter-2025-financial-results-on-november-12-2025-conference-call-and-provide-business-update-302593936.html

    PR NEWSWIRE
    27 Oct 2025
    Share Share
    Acurx Gets EMA Positive Opinion on PIP for Ibezapolstat in CDI
    Acurx Gets EMA Positive Opinion on PIP for Ibezapolstat in CDI

    30 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acurx-announces-positive-opinion-from-ema-on-pediatric-investigation-plan-for-ibezapolstat-use-in-children-with-c-difficile-infection-302570470.html

    PR NEWSWIRE
    30 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search